
About e-Nicotine Technology
e-Nicotine Technology is a company based in Los Gatos (United States) founded in 2012. e-Nicotine Technology has raised $3.98 million across 2 funding rounds from investors including Life Science Angels and North Texas Angel Network. e-Nicotine Technology operates in a competitive market with competitors including Pivot, Chrono Therapeutics, Velectron labs, ODEN Health Solutions and Lana Exprience, among others.
- Headquarter Los Gatos, United States
- SectorsHealthcare
- Website enicotinetechnology.com
- Social LinkedIn X
- Total Equity Funding$3.98M (USD)
in 2 rounds
- Latest Funding Round$400K (USD), Debt – Conventional
Oct 2014
- InvestorsLife Science Angels
& 1 more
Funding Insights of e-Nicotine Technology
e-Nicotine Technology has successfully raised a total of $3.98M across 2 strategic funding rounds. The most recent funding activity was a Debt β Conventional round of $400 thousand completed in October 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.98M
- Total Rounds 2
- Last Round Debt – Conventional β $400,000
- First Round $3.98M
(Oct 2013)
- Investors Count 2
All 2 funding rounds of e-Nicotine Technology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2014 | $400,000 | Debt – Conventional | β | β | β |
| Oct 2013 | $3.98M | Series A | β | β |
2 investors in total: 2 institutional.
Investors in e-Nicotine Technology
e-Nicotine Technology has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Life Science Angels and North Texas Angel Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life sciences startups are funded by a non-profit angel network. | – | lifescienceangels.com | Sunnyvale, United States | |
Early-stage companies are supported through angel investment funding. | – | northtexasangels.org | Dallas, United States |
Investor details for e-Nicotine Technology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of e-Nicotine Technology
3 dated milestones of e-Nicotine Technology across 2 years, from founding to its latest funding, stage changes and deals.
- Founded e-Nicotine Technology is founded.
- Funding First funding round of $4.0M.
- Funding Latest funding round, Debt β Conventional, of $400K.
Competitors of e-Nicotine Technology
e-Nicotine Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pivot, Chrono Therapeutics, Velectron labs, ODEN Health Solutions and Lana Exprience, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pivot.co | 2015 | San Carlos, United States | $43.3M | 60 | Digital health solutions for tobacco cessation are provided by Pivot. | |
| chronothera.com | 2004 | Waltham, United States | $82.2M | – | Develops transdermal nicotine replacement therapy for smoking cessation. | |
| voidelectron.com | 2018 | Bengaluru, India | $40,890 | – | Wearable anti-addiction devices are developed for customer support. | |
| odenhealthsolutions.com | 2020 | Coquitlam, Canada | – | – | Delivers comprehensive drug overdose detection devices for addiction treatment programs. | |
| lanaexperience.com | 2022 | Oman | – | – | Offers smart solutions for individuals dealing with substance use disorders. | |
| neurotype.io | 2019 | Minneapolis, United States | – | – | Next-generation neurofeedback and tools are provided to address craving triggers. |
Detailed competitors of e-Nicotine Technology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to e-Nicotine Technology
10 companies that operate in the same segment as e-Nicotine Technology (Health Monitoring & Wearables), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,660 | |
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Metabolic health is tracked via devices and fitness platforms. | 2019 | Bengaluru, Karnataka, India | USD 163.28 M | USD 65.48 M | 274 | |
Health-tracking smart rings and biosensors are developed for biometric monitoring. | 2013 | Oulu, North Ostrobothnia, Finland | USD 1.32 B | – | – | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
AI-based mobile app tracks and predicts menstrual cycles. | 2015 | London, England, United Kingdom | USD 269 M | – | – | |
Smartphone-enabled glucometers and diabetes management apps are provided. | 2015 | Delhi, Delhi, India | USD 50.83 M | USD 2.74 M | 142 | |
Provider of a fertility tracking app that doubles as birth control | 2013 | Stockholm, Sweden | USD 99.5 M | – | – | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about e-Nicotine Technology
e-Nicotine Technology was founded in 2012 and raised its 1st funding round 1 year after it was founded.
e-Nicotine Technology is headquartered in Los Gatos, United States. It is registered at Los Gatos, California, United States.
e-Nicotine Technology is a funded company, having raised a total of $3.98M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.98M, raised on Oct 2013.
e-Nicotine Technology (eNT) is a healthcare company to which has developed a device for nicotine delivery as a substitute of cigarettes. Produces a condensation aerosol of nicotine using a proprietary thermal drug delivery technology. The eNT platform produces the right dose of the right sized nicotine particles for deep lung delivery resulting in craving reduction. No carcinogens as found in cigarette smoke. The company claims that their product uses 40-70 less nicotine than conventional cigarettes or e-cigarettes.
e-Nicotine Technology's top competitors include Pivot, Velectron labs and Neurotype.
e-Nicotine Technology has 2 investors. Key investors include Life Science Angels, and North Texas Angel Network.